Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novartis prepares new IDH inhibitors for cancer

Oct. 6, 2014

BioMarin Pharmaceutical presents novel HDAC inhibitors

Oct. 6, 2014

Bristol-Myers Squibb reports new KCNA5 channel blockers for arrhythmia

Oct. 6, 2014

U.S. investigators synthesize novel anti-C. difficile antibodies

Oct. 6, 2014

AbbVie divulges novel PDE10A inhibitors

Oct. 6, 2014

Novel IRAK-4 inhibitors disclosed by Biogen Idec

Oct. 6, 2014

Boehringer Ingelheim patent discloses novel DPP-I inhibitors

Oct. 3, 2014

New AMPK activators designed at Merck & Co.

Oct. 3, 2014

AstraZeneca patent reports new inhibitors of activating mutant EGFRs

Oct. 3, 2014

Nanjing Sanhome Pharmaceutical patents novel anti-HCV nucleoside phosphoramidates

Oct. 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...